Cardio3 BioSciences Licenses Cardiac Stem Cell Technology From Mayo Clinic

BRAINE L'ALLEUD, BELGIUM and ROCHESTER, MN--(MARKET WIRE)--Jun 7, 2007 -- Cardio3 BioSciences (www.cardio3bio.com) and Mayo Clinic announced today that they have entered into a collaborative agreement related to the licensing of Mayo Clinic research, know-how and intellectual property in the field of cardiac commitment of stem cells.
MORE ON THIS TOPIC